Johnson R W
Ulster Med J. 1985 Aug;54 Suppl(Suppl):S81-5.
In two consecutive prospective randomised trials cyclosporin A has been compared with conventional immunosuppressive therapy (azathioprine and steroids) and with cyclosporin combined with steroids. The present report is a 4 year review and includes 165 patients.Cyclosporin A alone had a significant advantage over conventional therapy at both 1 and 3 years (p = 0.02) for both patient and graft survival. No significant difference was seen when cyclosporin was combined with steroids. Nephrotoxicity was the most troublesome side-effect of cyclosporin A - but this resolved spontaneously on withdrawal of the drug.
在两项连续的前瞻性随机试验中,将环孢素A与传统免疫抑制疗法(硫唑嘌呤和类固醇)以及环孢素与类固醇联合使用进行了比较。本报告是一项为期4年的回顾,包括165名患者。单独使用环孢素A在1年和3年时,在患者和移植物存活率方面均比传统疗法具有显著优势(p = 0.02)。环孢素与类固醇联合使用时未观察到显著差异。肾毒性是环孢素A最麻烦的副作用——但停药后可自发缓解。